BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on deadly brain tumors shows promise
Disease control Recruiting nowThis study tests a new way to treat aggressive brain cancers that have come back after standard therapy. It combines a targeted drug called cetuximab, given directly into the brain's blood vessels, with a second round of radiation. The goal is to see if this approach can safely s…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
Cannabis drug could extend life in aggressive brain cancer
Disease control Recruiting nowThis study tests whether adding a cannabis-based mouth spray (Nabiximols) to standard chemotherapy can help people with a returning, aggressive brain tumor called glioblastoma live longer. About 120 adults whose tumor has returned after initial treatment will be randomly assigned…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Sound waves plus drug may slow deadly brain tumor
Disease control Recruiting nowThis study tests whether adding focused ultrasound (NaviFUS) to the standard drug Avastin can help people with recurrent glioblastoma, an aggressive brain cancer. About 32 adults whose tumor has returned after prior treatment will be randomly assigned to receive Avastin alone or …
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Brain tumor drug delivered via pump shows promise in early trial
Disease control Recruiting nowThis early-stage study tests the safety of delivering the chemotherapy drug topotecan directly to the brain using a pump and catheter system (convection-enhanced delivery) in 6 people with recurrent IDH-mutant malignant glioma. The treatment involves four infusions over about a m…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New tile therapy for brain tumors under Real-World watch
Knowledge-focused Recruiting nowThis study is tracking 600 people with different types of brain tumors who receive GammaTile radiation therapy during surgery. The goal is to see how well the treatment works and how safe it is in everyday medical practice. Researchers will measure how long tumors stay away and h…
Matched conditions: BRAIN TUMOR, RECURRENT
Sponsor: GT Medical Technologies, Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC